Dianthus Therapeutics (DNTH) Stock: Buy, Sell, or Hold?
DNTH - Dianthus Therapeutics, Inc. Common Stock
$88.32
0.27 (0.31%)
▲
5d:
-2.63%
30d:
-17.16%
90d:
-6.38%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When DNTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DNTH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DNTH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DNTH is currently trading at $88.32, which is considered oversold relative to its 30-day fair value range of $93.36 to $109.65.
Technical Outlook: Technically, DNTH is in a uptrend. Immediate support is located at $84.72, while resistance sits at $104.55.
Market Sentiment: DNTH scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $140.80 (+59.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DNTH is in a uptrend. Immediate support is located at $84.72, while resistance sits at $104.55.
Market Sentiment: DNTH scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $140.80 (+59.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$93.36 -
$109.65
Company Quality Score
67/100
(BUY)
Options IV Signal
14th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
95.8%
Protect Your Profits
Holding DNTH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 14th percentile)
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 59.4% below Wall St target ($140.80)
- CAUTION: Bottoming setup, but lagging the sector by 29% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$93.36 -
$109.65
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$9.63
(10.9%)
Support & Resistance Levels
Support Level
$84.72
Resistance Level
$104.55
Current Trend
Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.15
Wall Street Target
$140.80
(+59.4%)
Revenue Growth (YoY)
294.3%
Share & Embed Analysis
Last updated: October 02, 2026 5:47 AM ET
Data refreshes hourly during market hours. Next update: 6:47 AM
Data refreshes hourly during market hours. Next update: 6:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ryan Savitz
SELL
8224 shares
2026-04-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 68 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 63 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$310 | 69 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 60 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
Advanced DNTH Option Strategies
Professional options setups generated by AI based on today's DNTH price and gamma walls.
